Montelukast
Product Images NDC 0143-9649

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 0143-9649). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by West Ward Pharmaceutical Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Monte Tab Alkem Figure 01)

Figure 1 (Monte Tab Alkem Figure 01)
This appears to be a graph showing the change in height in centimeters over a period of weeks on a certain treatment. The treatment options are Montelukast Sodium, Bodiomeinasono 338mg, and a placebo. The number of participants in each treatment group is also provided.*
FDA Label Image

Chemical Structure (Monte Tab Alkem Figure 02)

Chemical Structure (Monte Tab Alkem Figure 02)
FDA Label Image

Figure 2 (Monte Tab Alkem Figure 03)

Figure 2 (Monte Tab Alkem Figure 03)
FDA Label Image

Montelukast Sodium Tablets, 10 mg (Monte Tab Alkem Figure 04)

Montelukast Sodium Tablets, 10 mg (Monte Tab Alkem Figure 04)
This is a description of a medication with the National Drug Code (NDC) number 0143-9649-30. Each tablet of this medication contains 10.4 mg of Montelukast Sodium, which is equivalent to 10 mg of Montelukast. The medication should be stored at room temperature ranging from 15°C to 30°C and away from moisture and light. The container should be tightly closed and kept out of the reach of children. Patients can get the patient information leaflet from the pharmacist. The medication is manufactured by Kemwell Biopharma Put. Ltd. in Bonelore, 562123 India, for Unimark Remedies Ltd. It is intended for patients who are 15 years and older. The manufacturer is West-Ward Pharmaceuticals Inc. in Eatontown, NY, USA.*
FDA Label Image

Montelukast Sodium Chewable Tablets, 4 mg (Monte Tab Alkem Figure 05)

Montelukast Sodium Chewable Tablets, 4 mg (Monte Tab Alkem Figure 05)
NDC 0143-9651-30 Montelukast Sodium Chewable Tablets 4 mg. This medication is intended for pediatric patients age 2-5 and each chewable tablet contains 4.2 mg Montelukast Sodium equivalent to 4 mg Montelukast. It is important to keep the medication out of reach of children and to store it at controlled room temperature, away from light and moisture. The medication contains phenylalanine, which is a component of aspartame. The product information is available for a complete understanding of its usage. Lastly, the medication is manufactured by Kemwell Biopharma Put. Ltd in Bangalore, India and distributed by West-Ward Pharmaceutical Corp. *
FDA Label Image

Montelukast Sodium Chewable Tablets, 5 mg (Monte Tab Alkem Figure 06)

Montelukast Sodium Chewable Tablets, 5 mg (Monte Tab Alkem Figure 06)
This is a product description for Montelukast Sodium Chewable Tablets, with each tablet containing 5.2 mg Montelukast Sodium equivalent to 5 mg Montelukast. These tablets are intended for pediatric patients between 6 to 14 years of age, as an asthma control medication. Each packaging contains 30 chewable tablets and must be kept in a tightly sealed container protected from moisture and light. The product is manufactured in India and distributed by West-Ward Pharmaceutical Corp. A patient information leaflet must be dispensed to each buyer. The typical dosage is not given in the text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.